Thrivent Financial for Lutherans Sells 3,484 Shares of GSK plc (NYSE:GSK)
Thrivent Financial for Lutherans lowered its position in shares of GSK plc (NYSE:GSK – Free Report) by 6.5% in the 4th quarter, Holdings Channel.com reports. The fund owned 49,864 shares of the ...
JPMorgan Chase & Co. Reaffirms “Underweight” Rating for GSK (LON:GSK)
GSK (LON:GSK – Get Free Report)‘s stock had its “underweight” rating reaffirmed by equities research analysts at JPMorgan ...
Eli Lilly Vs. Novo Nordisk: Which Is The Better Bargain For Investors
Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain ...
pharmaphorum20h
GSK poaches Pfizer exec Dormitzer as new vaccines R&D chief
GlaxoSmithKline has found a replacement for head of vaccines R&D Emmanuel Hanon, who left the company for a US biotech earlier this year, hiring Phil Dormitzer from ...
pharmaphorum20h
GSK goes all-in on CureVac’s mRNA vaccines
GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...